LBPH - Longboard Pharmaceuticals Inc Qarzning balans kapitallashuviga nisbati
Kitob kapitalizatsiyasiga asoslangan moliyaviy leveraj koeffitsiyenti qarz olish dinamikasini namoyish etadi, bunda 0.01 Longboard Pharmaceuticals (LBPH) uchun ushbu metrikaning darajasini ko'rsatadi. Biznes qat'iy FDA nazorati va ulkan R&D xarajatlariga duch kelmoqda. Strategiya 5-HT2C retseptorlarini faollashtirish orqali kam uchraydigan tutqanoqlar uchun terapiyalarni ishlab chiqishga tayanadi. Yuqori ilmiy nufuz va muvaffaqiyatli klinik sinovlar brendga kuchli reputatsion o'sishni ta'minladi.
%20Qarzning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_LBPH_-_Longboard-Pharmaceuticals_-_Debt-to-Net-Assets-Ratio "Longboard Pharmaceuticals, Inc. - LBPH Qarzning balans kapitallashuviga nisbati (davr: 04.07.2022 - 07.12.2024) | 👁️GURU.Markets👁️")
Longboard Pharmaceuticals Inc (LBPH) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Kompaniyaning fundamental tahlili:Longboard Pharmaceuticals, LBPH
Longboard Pharmaceuticals kamyob nevrologik patologiyalar va bolalar epilepsiyasini davolash uchun yuqori marjali dori vositalari bo'yicha ixtisoslashgan. Balansdagi kapitalizatsiya doirasida qarz kapitalining taqsimotini tahlil qilish orqali investor majburiyatlarning kapitalga nisbatan ulushini baholaydi. Ushbu ko'rsatkich biznesning kreditorlarga bog'liqligini va soliq qalqonining samaradorligini o'lchaydi. Ushbu ko'rsatkichning pasayishi bozor shoklariga chidamlilikni kuchaytiradi, bu esa biofarmatsevtika startapining moliyaviy avtonomiyasini baholash uchun juda muhimdir.
Longboard Pharmaceuticals raqobatchilari
Qarzning balans qiymatiga nisbati BIIB (Biogen Inc.)|neurocrine.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Regencell Bioscience Holdings Limited (RGC)|AXSM: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati ACAD|XENE (Xenon Corp) - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Viking Therapeutics|Qarzning balans kapitallashuviga nisbati SUPN|Catalyst Pharmaceuticals, Inc. - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar DNLI (Denali)|HRMY - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Biohaven Corp BHVN|Balans kapitallashuviga qarzlar AMLX|TRVI - Qarzning sof aktivlarga nisbati|Praxis Precision Medicines, Inc. (PRAX) - Balans kapitallashuviga qarzlar|AVXL (Anavex) - Qarzning balans kapitallashuviga nisbati|Qarzning balans kapitallashuviga nisbati CBLL (CeriBell Corp)|Balans qiymatiga qarzlar prothena.com|Balans kapitallashuviga qarzlar ALEC|Balans kapitallashuviga qarzlar ANNX (annexonbio.com)|Qarzning balans kapitallashuviga nisbati Omeros|Qarzning sof aktivlarga nisbati Neurogene Inc NGNE|AC Immune Corp (ACIU) - Balans kapitallashuviga qarzlar|Voyager Corp (VYGR) - Qarzning balans qiymatiga nisbati|Qarzning balans qiymatiga nisbati Neumora Therapeutics NMRA|SCLX (scilexholding.com) - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Tevogen Bio TVGN|Qarzlarning balans kapitallashuviga nisbati Alpha Cognition Corp|Cognition Therapeutics (CGTX) - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati Inhibikase Pharma (IKT)|Balans kapitallashuviga qarzlar SAVA (Cassava Sciences, Inc.)|Assertio Holdings - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Coya (COYA)|VTGN: Qarzning sof aktivlarga nisbati|OVID (ovidrx.com) - Qarzning balans kapitallashuviga nisbati|Acumen Pharmaceuticals, Inc (ABOS) - Qarzning balans qiymatiga nisbati|CRVO (CervoMed Inc.) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar Alterity Therapeutics Ltd|Balans kapitallashuviga qarzlar CLNN (Clene Inc.)|Qarzning balans qiymatiga nisbati pepgen.com (PEPG)|JUNS: Balans kapitallashuviga qarzlar|RLMD - Balans qiymatiga qarzlar|Annovis Bio, Inc. - Qarzning balans qiymatiga nisbati|Grace Therapeutics, Inc. (GRCE) - Balans kapitallashuviga qarzlar|AIFF - Qarzning balans qiymatiga nisbati|Klotho Neurosciences (KLTO) - Qarzning balans kapitaliga nisbati|NRSN: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar Reviva Pharmaceuticals, Inc.|Balans kapitallashuviga qarzlar MTVA (MetaVia Inc)|Qarzning balans qiymatiga nisbati neuraxis.com (NRXS)|Balans kapitallashuviga qarzlar HSDT (Helius Medical Technologies)|Passage Bio Inc. - Balans kapitallashuviga qarzlar|NEUP - Qarzning balans kapitallashuviga nisbati|NERV: Qarzning balans kapitallashuviga nisbati|Athira Pharma, Inc. - Qarzning balans kapitallashuviga nisbati|ADXN (addextherapeutics.com) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati Alzamend Neuro Inc.|Qarzning balans kapitallashuviga nisbati Cyclerion|Balans kapitallashuviga qarzlar Protagenic Therapeutics (PTIX)|Qarzning balans kapitallashuviga nisbati KTTA (pasitheaclinics.com)|Cortigent (CRGT) - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati avenuetx.com ATXI|Balans kapitallashuviga qarzlar BrainStorm Cell Therapeutics (BCLI)|CARA: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Chromocell Therapeutics Corporation|Eliem Therapeutics Inc. (ELYM) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar ITCI (Intra-Cellular Therapies Inc.)|Balans qiymatiga qarzlar marinuspharma.com (MRNS)|Qarzning balans qiymatiga nisbati NKGN|Balans kapitallashuviga qarzlar NRBO (NeuroBo Pharmaceuticals Inc)|Qarzning balans kapitallashuviga nisbati Sage Therapeutics, Inc|Synaptogenix, Inc - Qarzning sof aktivlarga nisbati|TRVN (Trevena, Inc.) - Qarzning balans kapitallashuviga nisbati|VIGL: Balans qiymatiga qarzlar|Anew Medical (WENA) - Qarzning balans kapitallashuviga nisbati|CERE (Cerevel Therapeutics Inc) - Qarzning balans kapitallashuviga nisbati